Brief: Onxeo Says To Record Impairment Charge
March 14 (Reuters) - Onxeo Sa C4X.PA :
* ONXEO SA C4X.PA SAYS IT WILL RECORD AN IMPAIRMENT CHARGE
OF
ABOUT EUR 38 MILLION IN ITS 2017 CONSOLIDATED ACCOUNTS
* ONXEO SA C4X.PA - IMPAIRMENT CHARGE PURSUANT TO VALUE
TESTS
PERFORMED IN ACCORDANCE WITH IFRS ACCOUNTING STANDARDS
* ONXEO SA C4X.PA SAYS ACCOUNTING ADJUSTMENT DOES NOT
IMPACT IN
ANY WAY CO'S CURRENT OR FUTURE CASH BALANCE
Source text for Eikon: ID:nBwbLJNwga
Further company coverage: C4X.PA
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln